Multidisciplinary development of guidelines for ketamine treatment for treatment-resistant major depression disorder for use by adult specialist mental health services in New Zealand
BJPsych Open October 13, 2023 B. Beaglehole, P. Glue, Mike Clarke et al. 9 citations
New Zealand clinicians developed practical guidelines for using ketamine to treat treatment-resistant major depressive disorder in publicly funded specialist mental health services. The guidelines offer two treatment pathways: a test of responsiveness with intramuscular ketamine followed by a 3-month course of oral ketamine, aiming to maximize short-term benefits. The guidance was created through consultation with senior leadership, clinical pharmacy, psychiatrists, nursing, service users, and Māori mental health workers.